Página 4 - Melhores Câncer de testículo médicos - TOP-103 médicos

O Dr. Joseba Rebollo Liceaga traz mais de 30 anos de experiência em oncologia, especializando-se em cancro testicular na Quironsalud Torrevieja.

• Chefe de Oncologia na Clínica San Miguel de Navarra durante 13 anos
• Especialista em Oncologia Médica pela Clínica Universidad de Navarra
• Autor de pesquisas sobre eletroquimioterapia e tratamentos multidisciplinares
• Atualmente clinica na Quirónsalud Alicante

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

O Dr. Michael Van Kampen é um dedicado especialista em radioterapia na Clínica Nordwest, com foco em tratamentos de precisão contra o cancro.

• Especializar-se em radioterapia para cancro testicular
• Trabalhar na Clínica Nordwest, conhecida pelos cuidados oncológicos avançados
• Comprometer-se com planos de tratamento personalizados

O Professor Eduard Becht lidera uma associação interdisciplinar de uro-oncologia e possui mais de quatro décadas de experiência.

• Especializar-se em oncologia urológica, a área que inclui o cancro testicular.
• Ocupar um cargo de docente na prestigiada Universidade Goethe, em Frankfurt.
• Escrever mais de 100 artigos científicos na área.
• Realizar cirurgias tumorais com preservação de órgãos para manter a função.
• Ser distinguido com um doutoramento honorário por uma universidade europeia.

Serkan Deveci é professor de urologia com um forte foco de investigação na função sexual em doentes oncológicos. Trabalha no Hospital Medical Park Göztepe e concluiu uma bolsa de especialização em urologia nos EUA.

• Ser membro da American Urology Association e da North American Sexual Medicine Society
• Ser editor de secção da UpToDate – um recurso médico líder para médicos
• Escrever numerosas publicações internacionais sobre saúde sexual pós-cancro
• Realizar investigação sobre a gestão de efeitos secundários como a anejaculação após o tratamento

Chefe do Departamento de Urologia do Rambam Medical Center, o Dr. Amiel é especializado em oncologia urológica.

• Vasta experiência no tratamento de câncer testicular
• Liderar um dos principais departamentos de urologia de Israel
• Focar em procedimentos cirúrgicos oncológicos

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Especialista em oncologia cirúrgica com experiência em cancros abdominais e retroperitoneais, incluindo cancro testicular.

• Realizar cirurgias laparoscópicas e abertas para casos complexos
• Tratar uma ampla gama de condições oncológicas na cavidade abdominal
• Ser experiente no manejo de condições abdominais agudas

O Dr. Bogdan é especialista em cirurgias urológicas a laser e minimamente invasivas, incluindo procedimentos para cancro testicular no Dievo Surgery Center.

• Realizar orquiectomia e outras cirurgias urológicas
• Ser qualificado em técnicas laparoscópicas e a laser
• Gerir casos complexos com segundas opiniões

O Dr. Topcu concluiu a sua formação em centros oncológicos de prestígio nos EUA e no Canadá, trazendo experiência internacional para casos de cancro testicular.

• Certificado em oncologia médica com especialização (fellowship) nos EUA
• Membro das sociedades de oncologia europeia e americana (ESMO e ASCO)
• Atua no Hospital Universitário Biruni com cuidados oncológicos abrangentes
• Especializado em cancros urológicos masculinos, incluindo casos testiculares

Especialista em rádio-oncologia para cancro testicular no Hospital Emsey, com formação pela Universidade de Marmara.

• Concluir a especialização em rádio-oncologia na Universidade de Marmara
• Focar-se em técnicas de tratamento radioterápico de precisão
• Trabalhar no Hospital Emsey, um centro de oncologia de referência

O Dr. Tanriverdi é especializado em cirurgia urológica laparoscópica avançada e uro-oncologia no Hospital Liv Ulus.

• Focar em técnicas minimamente invasivas para cancros urológicos
• Membro da Associação Europeia de Urologia e da Associação Americana de Urologia
• Publicar 31 artigos de investigação internacionais sobre condições urológicas
• Especialista em procedimentos assistidos por robô para tratamento preciso do cancro

O Professor Associado Dr. Emrah Eraslan é especialista em oncologia médica, com foco em cancro testicular no Hospital Privado Koru Ankara.

• 12 anos de experiência em oncologia médica
• Formação no Hospital de Formação e Investigação Oncológica Dr. Abdurrahman Yurtaslan em Ancara
• Publicar vários artigos de investigação em oncologia
• Tratar diversos tipos de cancro, incluindo o cancro testicular